Atrion (ATRI) Total Debt to Capital

Atrion Corporation (ATRI) protects its market position through patent purity and strict FDA regulations, making it difficult for clients to switch suppliers. Business development is based on strategic alliances with ophthalmology and cardiology centers. This chart of the share price on GURU.Markets shows that the indicator is 0.00, supporting the company's focus on creating precision fluid delivery systems for oncology and surgery.

This metric measures the proportion of debt relative to equity, allowing investors to filter out market volatility and assess the real financial stability of the business by analyzing the balance between borrowed and equity capital. Monitoring leverage is critically important for Atrion Corporation (ATRI), as the high margins of serial production for unique medical components require optimal leverage to scale automated manufacturing facilities without the risk of bankruptcy.